Clinicopathological characteristics that distinguish BRCA-associated BC from sporadic cancer include a higher histological grade, hormone receptor negativity, early-onset of disease, and an elevated risk of synchronous bilateral BC [20,21,22,23,24]. The gene discussed is NR4A1; the disease is breast cancer.